Dianthus Therapeutics, Inc. (DNTH) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
Source: SeekingAlpha
2026-02-16 14:47:38 ET
Dianthus Therapeutics, Inc. (DNTH) Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 10:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Dianthus Therapeutics, Inc. (DNTH) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
Dianthus Therapeutics Inc.
NASDAQ: DNTH
DNTH Trading
4.58% G/L:
$62.885 Last:
493,029 Volume:
$60.16 Open:
DNTH Latest News
March 03, 2026 04:01:00 pm
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2026 07:00:00 am
Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
February 05, 2026 07:00:00 am
Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
DNTH Stock Data
$2,196,597,434
37,892,819
0.47%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
